Optimal timing of hemodilution for brain protection in a canine model of focal cerebral ischemia

Stroke

Volumn 27, Issue 5, 1996, Pages 906-912

  Yanaka, Kiyoyuki ^a   Camarata, Paul J ^a,b   Spellman, Stephen R ^a   McDonald, Drew E ^a   Heros, Roberto C ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

cerebral ischemia, focal; dogs; hemodilution; neuroprotection

Indexed keywords

DEXTRAN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CEREBRAL ARTERY; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; DOG; DOSE TIME EFFECT RELATION; HEMATOCRIT; HEMODILUTION; NEUROLOGIC EXAMINATION; NONHUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

EID: 0029879191     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.5.906     Document Type: Article

References (77)

1. Cole DJ, Schell RM, Przybelski RJ, Drummond JC, Bradley K. Focal cerebral ischemia in rats: effect of hemodilution with alpha-alpha cross-linked hemoglobin on CBF. J Cereb Blood Flow Metab. 1992;12:971-976.
2. Lee SH, Heros RC, Mullan JC, Korosue K. Optimum degree of hemodilution for brain protection in a canine model of focal cerebral ischemia. J Neurosurg. 1994;80:469-475.
3. Ohtaki M, Tranmer BI. Role of hypervolemic hemodilution in focal cerebral ischemia of rats. Surg Neurol. 1993;40:196-206.
4. Tu YK, Heros RC, Candia G, Hyodo A, Lagree K, Callahan R, Zervas NT, Karacostas D. Isovolemic hemodilution in experimental focal cerebral ischemia, part 1: effect on hemodynamics, hemorheology, and intracranial pressure. J Neurosurg. 1988;69:72-81.
5. Wood JH, Simeone FA, Kron RE, Snyder LL. Experimental hypervolemic hemodilution: physiologic correlations of cortical blood flow, cardiac output and intracranial pressure with fresh blood viscosity and plasma volume. Neurosurgery. 1984;14:709-723.
6. Hyodo A, Heros RC, Tu YK, Ogilvy C, Graichen R, Lagree K, Korosue K. Acute effects of isovolemic hemodilution with crystalloids in a canine model of focal cerebral ischemia. Stroke. 1989; 20:534-540.
7. Wood JH, Simeone FA, Fink EA, Golden MA. Hypervolemic hemodilution in experimental focal cerebral ischemia: elevation of cardiac output, regional cortical blood flow, and ICP after intravascular volume expansion with low molecular weight dextran. J Neurosurg. 1983;59:500-509.
8. Italian Acute Stroke Study Group. Haemodilution in acute stroke: results of the Italian haemodilution trial. Lancet. 1988;1:318-321.
9. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in acute ischemic stroke, I: results in the total patient population. Stroke. 1987;18:691-699.
10. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in acute ischemic stroke: results of subgroup analyses. Stroke. 1988;19:464-471.
11. Crowell RM, Olsson Y, Klatzo I, Ommaya A. Temporary occlusion of the middle cerebral artery in the monkey: clinical and pathological observations. Stroke. 1970;1:439-448.
12. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U, Ojemann RG. Threshold of focal cerebral ischemia in awake monkeys. J Neurosurg. 1981;54:773-782.
13. Kaplan B, Brint S, Tanabe J, Jacewicz M, Wang XJ, Pulsinelli W. Temporal threshold for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke. 1991;22:1032-1039.
14. Sundt TM Jr, Grant WC, Garcia JH. Restoration of middle cerebral artery flow in experimental infarction. J Neurosurg. 1969; 31:311-322.
15. Carneiro JJ, Donald DE. Blood reservoir function of dog spleen, liver, and intestine. Am J Physiol. 1977;232:H67-H72.
16. Tu YK, Heros RC, Karacostas D, Liszczak T, Hyodo A, Candia G, Zervas NT, Lagree K. Isovolemic hemodilution in experimental focal cerebral ischemia, part 2: effect on regional cerebral blood flow and size of infarction. J Neurosurg. 1988;69:82-91.
17. de la Torre E, Netsky MG, Meschen I. Intracranial and extracranial circulations in the dog: anatomic and angiographie studies. Am J Anal. 1959;105:343-381.
18. Mullan JC, Korosue K, Heros RC. The use of somatosensory evoked potential monitoring to produce a canine model of uniform, moderately severe stroke with permanent arterial occlusion. Neurosurgery. 1993;32:967-973.
19. Seaman GVF, Hissen W, Lino L, Swank RL. Physico-chemical changes in blood arising from dextran infusions. Clin Sci. 1965;29: 293-304.
20. Shoemaker WC. Comparison of the relative effectiveness of whole blood transfusions and various types of fluid therapy in resuscitation. Crit Care Med. 1976;4:71-78.
21. Crowell RM, Olsson Y. Effect of extracranial-intracranial vascular bypass graft on experimental acute stroke in dog. J Neurosurg. 1973; 38:26-31.
22. Laurent JP, Lawner P, Simeone FA, Fink E, Rorke LB. Qualitative measurement of cerebral infarction using ultraviolet fluorescence. Surg Neurol. 1982;17:320-324.
23. Korosue K, Heros RC, Ogilvy CS, Hyodo A, Tu YK, Graichen R. Comparison of crystalloids and colloids for hemodilution in a model of focal cerebral ischemia. J Neurosurg. 1990;73:576-584.
24. Astrup J. Energy-requiring cell functions in the ischemic brain: their critical supply and possible inhibition in protective therapy. J Neurosurg. 1982;56:482-497.
25. Heros RC, Korosue K. Hemodilution for cerebral ischemia. Stroke. 1989;20:423-427.
26. Hossmann KA, Kerckhoff W, Matsuoka Y. Treatment of cerebral ischemia by hemodilution. Bibl Haematol. 1981;47:77-85.
27. Korosue K, Heros RC. Mechanism of cerebral blood flow augmentation by hemodilution in rabbits. Stroke. 1992;23:1487-1493.
28. Wood JH, Kee DB Jr. Hemorheology of the cerebral circulation in stroke. Stroke. 1985;16:765-772.
29. Stone HO, Thompson HK Jr, Schmidt-Nielsen K. Influence of erythrocytes in blood viscosity. Am J Physiol. 1968;214:913-918.
30. Maruyama M, Shimoji K, Ichikawa T, Hashiba M, Naito E. The effects of extreme hemodilutions on the autoregulation of cerebral blood flow, electroencephalogram and cerebral metabolic rate of oxygen in the dog. Stroke. 1985;16:675-679.
31. Paulson OB, Parving HH, Olesen J, Skinhøj E. Influence of carbon monoxide and of hemodilution on cerebral blood flow and blood gases in man. J Appl Physiol. 1973;35:111-116.
32. Dintenfass L. Inversion of the Fahreus-Lindqvist phenomenon in blood flow through capillaries of diminishing radius. Nature. 1967; 215:1099-1100.
33. Fahreus R, Lindqvist T. The viscosity of blood in narrow capillary tubes. Am J Physiol. 1931;96:562-568.
34. Häggendal E, Nilsson NJ, Norbäck B. Effect of blood corpuscle concentration on cerebral blood flow. Acta Chir Scand. 1966;364: 3-12.
35. Häggendal E, Norbäck B. Effect of viscosity on cerebral blood flow. Acta Chir Scand. 1966;364:13-22.
36. Sakuta S. Blood filterability in cerebrovascular disorders, with special reference to erythrocyte deformability and ATP content. Stroke. 1981;12:824-827.
37. Schmid-Schönbein H. Factors promoting and preventing the fluidity of blood. In: Effros RM, Schmid-Schönbein H, Ditzel J, eds. Microcirculation. New York, NY: Academic Press; 1981:249-266.
38. Goslinga H, Eijzenbach V, Heuvelmans JHA, de Vries VDL, Melis VMJ, Schmid-Schönbein H, Bezemer PD. Custom-tailored hemodilution with albumin and crystalloids in acute ischemic stroke. Stroke. 1992;23:181-188.
39. Kee DB Jr, Wood JH. Rheology of the cerebral circulation. Neurosurgery. 1984;15:125-131.
40. Koller M, Haenny P, Hess K, Weiger D, Zangger P. Adjusted hypervolemic hemodilution in acute ischemic stroke. Stroke. 1990; 21:1429-1434.
41. Strand T, Asplund K, Eriksson S, Hägg E, Lithner F, Wester PO. A randomized controlled trial of hemodilution therapy in acute ischemic stroke. Stroke. 1984;15:980-989.
42. Strand T. Evaluation of long-term outcome and safety after hemodilution therapy in acute ischemic stroke. Stroke. 1992;23: 657-662.
43. Sundt TM Jr, Waltz AG. Hemodilution and anticoagulation: effects of the microvasculature and microcirculation of the cerebral cortex after arterial occlusion. Neurology. 1967;17:230-238.
44. Grotta JC. Current status of hemodilution in acute cerebral ischemia. Stroke. 1987;18:689-690.
45. de Couten-Myers GM, Kleinholz M, Holm P, Devoe G, Schmitt G, Wagner KR, Myers RE. Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med. 1992;21:120-126.
46. del Zoppo GJ, Copeland BR, Anderchek K, Hacke W, Koziol JA. Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction. Stroke. 1990;21:596-601.
47. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R Jr, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolie stroke. Ann Neurol. 1992;32:78-86.
48. Kummer RV, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke. 1992;23:646-652.
49. Lyden PD, Zivin JA. Hemorrhagic transformation after cerebral ischemia: mechanism and incidence. Cerebrovasc Brain Metab Rev. 1993;5:1-16.
50. Phillips DA, Fischer M, Smith TW, Davis MA, Pang RHL. The effect of a new tissue plasminogen activator analogue, Fb-Fb-CF, on cerebral reperfusion in a rabbit embolie stroke model. Ann Neurol. 1989;25:281-285.
51. Ogata J, Yutani C, Imakita M, Ishibashi-Ueda H, Saku Y, Minematsu K, Sawada T, Yamaguchi T. Hemorrhagic infarct of the brain without a reopening of the occluded arteries in cardioembolic stroke. Stroke. 1989;20:876-883.
52. Saku Y, Choki J, Waki R, Masuda J, Tamaki K, Fujishima M, Ogata J. Hemorrhagic infarct induced by arterial hypertension in cat brain following middle cerebral artery occlusion. Stroke. 1990; 21:589-595.
53. Yamashita K, Kobayashi S, Yamaguchi S, Tsunematsu T. Effect of haemodilution on experimental cerebral ischemia. Clin Exp Neurol. 1989;28:23-31.
54. Michenfelder JD, Milde JH. Influence of anesthetics on metabolic, functional and pathological responses to regional cerebral ischemia. Stroke. 1975;6:405-410.
55. Smith AL, Hoff JT, Nielsen SL, Larson CP. Barbiturate protection in acute focal cerebral ischemia. Stroke. 1974;5:1-7.
56. Maekawa T, Sakabe T, Takeshita H. Diazepam blocks cerebral metabolism and circulatory responses to local anesthetic-induced seizures. Anesthesiology. 1974;41:389-391.
57. Heros RC. Carotid endarterectomy in patients with intraluminal thrombus. Stroke. 1988;19:667-668. Editorial.
58. Loftus CM, Quest DO. Technical issues in carotid artery surgery 1995. Neurosurgery. 1995;36:629-647.
59. Myers SI, Valentine J, Chervu A, Bowers BL, Clagett GP. Saphenous vein patch versus primary closure for carotid endarterectomy: long-term assessment of a randomized prospective study. J Vasc Surg. 1994;19:15-22.
60. Ojemann RG, Heros RC. Carotid endarterectomy: to shunt or not to shunt? Arch Neurol. 1980;43:708-714.
61. Sundt TM Jr, Sharbrough FW, Anderson RE, Michenfelder JD. Cerebral blood flow measurements and electroencephalograms during carotid endarterectomy. J Neurosurg. 1974;41:310-320.
62. Rosomoff HL. Hypothermia and cerebral vascular lesions, I: experimental interruption of the middle cerebral artery during hypothermia. J Neurosurg. 1956;13:244-255.
63. Rosomoff HL. Hypothermia and cerebral vascular lesions, I: experimental interruption of the middle cerebral artery followed by induction of hypothermia. Arch Neurol Psychiatry. 1957;78:454-464.
64. Dzyurt E, Graham D, McCulloch J, Woodruff G. The NMDA receptor antagonist MK-801 reduces focal ischaemic brain damage in the cat. J Cereb Blood Flow Metab. 1987;7:S146.
65. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia, part II: mechanism of damage and treatment. J Neurosurg. 1992;77:337-354.
66. American Nimodipine Study Group. Clinical trial of nimodipine in acute ischemic stroke. Stroke. 1992;23:3-8.
67. Hall ED, Pazara KE, Braughler JM, Linseman KL, Jacobson EJ. Nonsteroidal lazaroid U78517F in models of focal and global ischemia. Stroke. 1990;21(suppl III):III-83-III-87.
68. Martz D, Rayos G, Schielke GP, Betz AL. Allopurinol and dimethylthiourea reduce brain infarction following middle cerebral artery occlusion in rats. Stroke. 1989;20:488-494.
69. 1 ganglioside. J Neurosci Res. 1984;12:485-492.
70. Weinstein PR, Anderson GG, Telles DA. Neurological deficit and cerebral infarction after temporary middle cerebral artery occlusion in unanesthetized cats. Stroke. 1986;17:318-324.
71. 1 hippocampal ischemia neuronal injury. Neurosci Lett. 1989;101:299-304.
72. Buchan A, Li H, Cho S, Pulsinelli W. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci Lett. 1991;132: 255-258.
73. Gill R, Nordholm L, Lodge D. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischemia model. Brain Res. 1992;580:35-43.
74. Overgaard K, Sereghy T, Pedersen H, Boysen G. Effect of delayed thrombolysis with rt-PA in a rat embolie stroke model. J Cereb Blood Flow Metab. 1994;14:472-477.
75. Alberts MJ, Perry A, Dawson DW, Bertels C. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke. 1992;23:352-356.
76. Camarata PJ, Heros RC, Latchaw RE. 'Brain attack': the rationale for treating stroke as a medical emergency. Neurosurgery. 1994;34: 144-158.
77. Yanaka K, Kamezaki T, Kobayashi E, Nose T. Current status of surgical management for occlusive cerebrovascular disease. No To Shinkei. 1991;43:913-916.